Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients
Yetrib Hathout, Ramya Marathi, Sree Rayavarapu, et al.
Human Molecular Genetics (2014) Vol. 23, Iss. 24, pp. 6458-6469
Open Access | Times Cited: 113

Showing 1-25 of 113 citing articles:

The Pathogenesis and Therapy of Muscular Dystrophies
Simon Guiraud, Annemieke Aartsma‐Rus, Natássia M. Vieira, et al.
Annual Review of Genomics and Human Genetics (2015) Vol. 16, Iss. 1, pp. 281-308
Open Access | Times Cited: 279
Contemporary Cardiac Issues in Duchenne Muscular Dystrophy
Elizabeth M. McNally, Jonathan R. Kaltman, D. Woodrow Benson, et al.
Circulation (2015) Vol. 131, Iss. 18, pp. 1590-1598
Open Access | Times Cited: 272
Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy
Yetrib Hathout, Edward N. Brody, Paula R. Clemens, et al.
Proceedings of the National Academy of Sciences (2015) Vol. 112, Iss. 23, pp. 7153-7158
Open Access | Times Cited: 267
Phase 1/2 trial of brogidirsen: Dual-targeting antisense oligonucleotides for exon 44 skipping in Duchenne muscular dystrophy
Hirofumi Komaki, Eri Takeshita, Katsuhiko Kunitake, et al.
Cell Reports Medicine (2025), pp. 101901-101901
Open Access | Times Cited: 2
BMN 351-Induced Exon Skipping and Dystrophin Expression in Skeletal and Cardiac Muscle Lead to Preservation of Motor Function in a Mouse Model of Exon 51 Skip-Amenable Duchenne Muscular Dystrophy
Todd Oppeneer, Yulan Qi, Joshua Henshaw, et al.
Nucleic Acid Therapeutics (2025)
Closed Access | Times Cited: 2
Degenerative and regenerative pathways underlying Duchenne muscular dystrophy revealed by single-nucleus RNA sequencing
Francesco Chemello, Zhaoning Wang, Hui Li, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 47, pp. 29691-29701
Open Access | Times Cited: 125
A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophy
Nathalie Goemans, Eugenio Mercuri, Е. Д. Белоусова, et al.
Neuromuscular Disorders (2017) Vol. 28, Iss. 1, pp. 4-15
Open Access | Times Cited: 115
Biomarkers for Duchenne muscular dystrophy: myonecrosis, inflammation and oxidative stress
Miranda D. Grounds, Jessica R. Terrill, Basma A. Al-Mshhdani, et al.
Disease Models & Mechanisms (2020) Vol. 13, Iss. 2
Open Access | Times Cited: 107
Myokines and Heart Failure: Challenging Role in Adverse Cardiac Remodeling, Myopathy, and Clinical Outcomes
Alexander Е. Berezin, Alexander A. Berezin, Michael Lichtenauer
Disease Markers (2021) Vol. 2021, pp. 1-17
Open Access | Times Cited: 64
Muscle-Derived Proteins as Serum Biomarkers for Monitoring Disease Progression in Three Forms of Muscular Dystrophy
Peter M. Burch, Oksana Pogoryelova, Richard A. Goldstein, et al.
Journal of Neuromuscular Diseases (2015) Vol. 2, Iss. 3, pp. 241-255
Open Access | Times Cited: 88
Clinical utility of serum biomarkers in Duchenne muscular dystrophy
Yetrib Hathout, Haeri Seol, M H Han, et al.
Clinical Proteomics (2016) Vol. 13, Iss. 1
Open Access | Times Cited: 74
Establishment of a highly sensitive sandwich ELISA for the N-terminal fragment of titin in urine
Nobuhiro Maruyama, Tsuyoshi Asai, Chiaki Abe, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 70
Emerging importance of oxidative stress in regulating striated muscle elasticity
Lisa Beckendorf, Wolfgang A. Linke
Journal of Muscle Research and Cell Motility (2014) Vol. 36, Iss. 1, pp. 25-36
Open Access | Times Cited: 69
Anti-inflammatory drugs for Duchenne muscular dystrophy: focus on skeletal muscle-releasing factors
Yoshitsugu Aoki, Shouta Miyatake, Yuko Shimizu‐Motohashi, et al.
Drug Design Development and Therapy (2016) Vol. Volume 10, pp. 2745-2758
Open Access | Times Cited: 68
Serum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies
Jérémy Rouillon, Jérôme Poupiot, Aleksandar Zocevic, et al.
Human Molecular Genetics (2015) Vol. 24, Iss. 17, pp. 4916-4932
Open Access | Times Cited: 65
Progressive muscle proteome changes in a clinically relevant pig model of Duchenne muscular dystrophy
Thomas Fröhlich, Elisabeth Kemter, Florian Flenkenthaler, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 65
Biomarkers of Duchenne muscular dystrophy: current findings
Cristina Al‐Khalili Szigyarto, Pietro Spitali
Degenerative Neurological and Neuromuscular Disease (2018) Vol. Volume 8, pp. 1-13
Open Access | Times Cited: 63
Downregulation of the NLRP3 inflammasome by adiponectin rescues Duchenne muscular dystrophy
Raphaël Boursereau, Michel Abou‐Samra, Sophie Lecompte, et al.
BMC Biology (2018) Vol. 16, Iss. 1
Open Access | Times Cited: 63
Adiponectin and Its Mimics on Skeletal Muscle: Insulin Sensitizers, Fat Burners, Exercise Mimickers, Muscling Pills … or Everything Together?
Michel Abou‐Samra, Camille M. Selvais, Nicolas Dubuisson, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2620-2620
Open Access | Times Cited: 52
TLR4 is a regulator of trained immunity in a murine model of Duchenne muscular dystrophy
Salyan Bhattarai, Qian Li, Jun Ding, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 38
NLRP3 Contributes to Sarcopenia Associated to Dependency Recapitulating Inflammatory-Associated Muscle Degeneration
Eduardo Antuña, Yaiza Potes, Francisco Javier Baena-Huerta, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1439-1439
Open Access | Times Cited: 6
Identification of novel, therapy-responsive protein biomarkers in a mouse model of Duchenne muscular dystrophy by aptamer-based serum proteomics
Anna Coenen-Stass, Graham McClorey, Raquel Manzano, et al.
Scientific Reports (2015) Vol. 5, Iss. 1
Open Access | Times Cited: 57
Tracking disease progression non‐invasively in Duchenne and Becker muscular dystrophies
Pietro Spitali, Kristina Hettne, Roula Tsonaka, et al.
Journal of Cachexia Sarcopenia and Muscle (2018) Vol. 9, Iss. 4, pp. 715-726
Open Access | Times Cited: 57
Label‐free mass spectrometric analysis of the mdx‐4cv diaphragm identifies the matricellular protein periostin as a potential factor involved in dystrophinopathy‐related fibrosis
Ashling Holland, Paul Dowling, Paula Meleady, et al.
PROTEOMICS (2015) Vol. 15, Iss. 13, pp. 2318-2331
Closed Access | Times Cited: 53
Involvement of adiponectin in the pathogenesis of dystrophinopathy
Michel Abou‐Samra, Sophie Lecompte, Olivier Schakman, et al.
Skeletal Muscle (2015) Vol. 5, Iss. 1
Open Access | Times Cited: 50
Page 1 - Next Page

Scroll to top